Compare HIVE & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HIVE | TNDM |
|---|---|---|
| Founded | 1987 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2017 | 2013 |
| Metric | HIVE | TNDM |
|---|---|---|
| Price | $2.54 | $18.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 19 |
| Target Price | $6.44 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 15.1M | 1.5M |
| Earning Date | 02-17-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $297,791,000.00 | ★ $1,014,736,000.00 |
| Revenue This Year | $169.51 | $8.11 |
| Revenue Next Year | $39.45 | $11.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 158.32 | 7.93 |
| 52 Week Low | $1.73 | $10.00 |
| 52 Week High | $7.84 | $29.65 |
| Indicator | HIVE | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 34.19 | 61.29 |
| Support Level | $2.04 | $17.79 |
| Resistance Level | $2.75 | $18.23 |
| Average True Range (ATR) | 0.20 | 1.01 |
| MACD | -0.03 | 0.21 |
| Stochastic Oscillator | 1.63 | 93.31 |
HIVE Digital Technologies Ltd is a sustainable-energy-focused digital infrastructure company that provides infrastructure solutions through the operation of Tier-1 and Tier-3 data centers. Its computing power is used for high-performance computing (HPC) and for generating hashrate sold to mining pools for cryptocurrency mining. The Company uses cash flow from its hashrate services business to support the expansion of its AI and HPC operations through its subsidiary. The Company focuses on Canada, Sweden, and Paraguay, where low-cost renewable power supports its operations and expansion. It operates in one segment with two revenue streams: the mining and sale of digital currencies and high-performance computing hosting. The majority of its revenue is generated from Bermuda.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.